In ACC, a key signaling axis involves tumor-derived CCL2 recruiting CCR2+ TAMs, which in turn secrete GDNF to drive tumor cell proliferation via the RET pathway (118) (Figure 3D). This evidence concerns the gene CCL2 and neoplasm.